Organism name | Bupleurum rotundifolium L. |
---|---|
Genus | Bupleurum |
Family | Apiaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Bupleurum rotundifolium |
---|---|
Linked NCBI taxonomy ID | 90446 |
Linked level | species |
Family in NCBI taxonomy | Apiaceae |
---|---|
ID | 4037 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005413 |
Rutin
/ Birutan / 3-Rutinosylquercetin / Quercetin 3-O-rutinoside / (+)-Quercetin 3-O-rutinoside / Quercetin 3-O-beta-rutinoside / (+)-Quercetin 3-O-beta-rutinoside / 3,3',4',5,7-Pentahydroxyflavone 3-rutinoside / Quercetin 3-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside |
CHEMBL32579
CHEMBL310754 CHEMBL182108 CHEMBL226335 CHEMBL502782 CHEMBL1436093 CHEMBL1532989 |
D012431
|
25 / 18 / 16 | 29 / 8 | No. 1 | No. 15 | |
C00005373 |
Hirsutrin
/ Isoquercetin / Isoquercetrin / (-)-Isoquercetrin / Quercetin 3-glucoside / Quercetin 3-O-beta-D-glucoside / Quercetin-3-O-beta-D-glucopyranoside / Quercetin 3-O-beta-D-glucopyranoside / (-)-Quercetin-3-O-beta-D-glucopyranoside |
CHEMBL33027
CHEMBL309323 CHEMBL250450 CHEMBL251254 CHEMBL457304 CHEMBL1098724 CHEMBL2337335 CHEMBL2337336 |
38 / 43 / 34 | No. 2 | No. 15 | |||
C00005525 |
Isorhamnetin 3-glucoside
/ Isorhamnetin 3-O-glucoside / Isorhamnetin 3-O-beta-D-glucoside / Isorhamnetin 3-O-beta-D-glucopyranoside |
CHEMBL234316
CHEMBL516621 |
1 / 1 / 0 | No. 2 | No. 15 | |||
C00005374 |
Quercetin
|
CHEMBL82242
CHEMBL479232 CHEMBL1437696 |
C012526
|
14 / 2 / 2 | 2 / 1 | No. 2 | No. 15 | |
C00004635 |
Isorhamnetin
/ 3'-O-Methylquercetin / 3,4',5,7-Tetrahydroxy-3'-methoxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL379064
|
C047368
|
12 / 10 / 13 | 10 / 0 | No. 3 | No. 15 |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00004635 C00005373 C00005374 C00005413 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00004635 C00005373 C00005374 C00005413 | 1 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00004635 C00005373 C00005374 C00005413 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00005373 C00005374 C00005413 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00004635 C00005373 C00005374 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00005373 C00005374 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00005373 C00005413 | 0 / 3 |
P06746 | DNA polymerase beta | Enzyme | C00005373 C00005413 | 0 / 0 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00005373 C00005525 | 1 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00005373 C00005413 | 1 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00005373 C00005413 | 4 / 3 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00005373 C00005413 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00005373 C00005413 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00005373 C00005413 | 2 / 0 |
P07237 | Protein disulfide-isomerase | Enzyme | C00005373 C00005374 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00005373 C00005413 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00005373 C00005413 | 1 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00005373 C00005413 | 4 / 2 |
Q9Y253 | DNA polymerase eta | Enzyme | C00005373 C00005374 | 1 / 1 |
P15121 | Aldose reductase | Enzyme | C00005373 C00005374 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00005373 C00005374 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00005413 | 0 / 1 |
O75496 | Geminin | Unclassified protein | C00005373 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00005413 | 0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00005373 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00005374 | 0 / 0 |
P27487 | Dipeptidyl peptidase 4 | S9B | C00005413 | 0 / 1 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00005373 | 0 / 0 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00005373 | 0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00005373 | 3 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00005374 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00005413 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00005413 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00004635 | 4 / 4 |
P06276 | Cholinesterase | Hydrolase | C00005413 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00005373 | 1 / 1 |
P04745 | Alpha-amylase 1 | Enzyme | C00004635 | 0 / 0 |
P04792 | Heat shock protein beta-1 | Unclassified protein | C00004635 | 2 / 1 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | C00005373 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00004635 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00005413 | 3 / 3 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00004635 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00005413 | 1 / 1 |
P22303 | Acetylcholinesterase | Hydrolase | C00005413 | 1 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00005373 | 0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00005373 | 1 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00005373 | 11 / 10 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00005374 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00005373 | 6 / 4 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00004635 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00005373 | 0 / 0 |
P34949 | Mannose-6-phosphate isomerase | Enzyme | C00005373 | 1 / 1 |
P48147 | Prolyl endopeptidase | S9A | C00005413 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00005373 | 4 / 1 |
Q9NPH5 | NADPH oxidase 4 | Enzyme | C00005373 | 0 / 0 |
Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | C00005374 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00004635 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00004635 | 1 / 2 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00005373 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00005373 | 1 / 4 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00005413 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00004635
C00005374
C00005413
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00004635
C00005374
C00005413
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00004635
C00005413
|
3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00005413
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00004635
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00004635
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00004635
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00004635
|
4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00004635
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00004635
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00005413
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00005413
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00005413
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00005413
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00005413
|
847 | CAT | catalase (EC:1.11.1.6) |
C00005413
|
873 | CBR1, CBR, SDR21C1, hCBR1 | carbonyl reductase 1 (EC:1.1.1.189 1.1.1.197 1.1.1.184) |
C00005413
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00005413
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00004635
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00005413
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00005413
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00005413
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00005413
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00005413
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00005413
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00005413
|
3667 | IRS1, HIRS-1 | insulin receptor substrate 1 |
C00005413
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00005413
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00005413
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00005413
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00005413
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00005413
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00005413
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00005413
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00005413
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00005413
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#606595 | Charcot-marie-tooth disease, axonal, type 2f; cmt2f |
P04792
|
#602579 | Congenital disorder of glycosylation, type ib; cdg1b |
P34949
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#608634 | Neuronopathy, distal hereditary motor, type iib; hmn2b |
P04792
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00856 | Distal hereditary motor neuropathies (dHMN) |
P04792
(related)
|
H00213 | Hypophosphatasia |
P05186
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00032 | Thyroid cancer |
P27487
(marker)
|
H00118 | Congenital disorders of glycosylation (CDG) type I |
P34949
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00192 | Xanthinuria |
P47989
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D010146 | Pain |
C00005374
|
D001424 | Bacterial Infections |
C00005413
|
D003092 | Colitis |
C00005413
|
D004409 | Dyskinesia, Drug-Induced |
C00005413
|
D015212 | Inflammatory Bowel Diseases |
C00005413
|
D007674 | Kidney Diseases |
C00005413
|
D028361 | Mitochondrial Diseases |
C00005413
|
D010243 | Paralysis |
C00005413
|
D013276 | Stomach Ulcer |
C00005413
|